The goji berry contains unique polysaccharides (natural complex carbohydrates) that exhibit powerful anti-cancer properties. A study in 2001 showed that goji berry polysaccharides inhibited the growth of human leukemia cells. Another study in 1994 showed that goji berry polysaccharides combined with a standard cancer drug LAK/IL-2, was 254% (2.5 times) more effective at reducing tumors than using the standard cancer drug by itself.
With such promising results, it makes you wonder why the goji berry hasn't been extensively trialed in cancer treatment, especially considering all the billions invested into cancer research each year. It's likely because the goji berry is a natural food product which can't be patented, and therefore it wouldn't be a profitable investment for drug companies.
Several research studies identify powerful anti-cancer properties of the goji berry (Lycium barbarum). The following medical articles are found in the United States of America, National Library of Medicine:
Medical Research on the use of goji berries in cancer prevention and treatment:
1. Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment
of 75 cancer patients, published in Zhonghua Zhong Liu Za Zhi. 1994 Nov;16(6):428-31.
2. Inhibiting the growth of human leukemia cells by Lycium barbarum polysaccharide, published in Wei Sheng Yan
Jiu. 2001 Nov;30(6):333-5.
3. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells, published in Eur J Pharmacol. 2003 Jun 27;471(3):217-22.
4. Effect of Lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis, published in Life Science. 2005 Mar 18;76(18):2115-24.
5. Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum, published in Int Immunopharmacol. 2004 Apr;4(4):563-9.
6. Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice, published in Zhong Xi Yi Jie He Xue Bao. 2005 Sep;3(5):374-7.
Source:- http://naturallygoji.co.uk/anti_cancer.htm
No comments:
Post a Comment